1MF8 image
Deposition Date 2002-08-09
Release Date 2002-10-16
Last Version Date 2025-03-26
Entry Detail
PDB ID:
1MF8
Title:
Crystal Structure of human calcineurin complexed with cyclosporin A and human cyclophilin
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.10 Å
R-Value Free:
0.30
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CALMODULIN-DEPENDENT CALCINEURIN A SUBUNIT, ALPHA ISOFORM
Gene (Uniprot):PPP3CA
Chain IDs:A
Chain Length:373
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Molecule:CALCINEURIN B SUBUNIT ISOFORM 1
Gene (Uniprot):PPP3R1
Chain IDs:B
Chain Length:170
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Molecule:PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A
Gene (Uniprot):PPIA
Chain IDs:C
Chain Length:165
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Molecule:CYCLOSPORIN A
Chain IDs:D
Chain Length:11
Number of Molecules:1
Biological Source:TOLYPOCLADIUM INFLATUM
Peptide-like Molecules
PRD_000142
Primary Citation
Crystal Structure of Human Calcineurin Complexed with Cyclosporin a and Human Cyclophilin
Proc.Natl.Acad.Sci.USA 99 13522 ? (2002)
PMID: 12357034 DOI: 10.1073/PNAS.212504399

Abstact

Calcineurin (Cn), a Ca(2+)/calmodulin-dependent Ser/Thr protein phosphatase, is an important participant in signaling pathways that activate T cells. It is the target of the immunosuppressive drugs cyclosporin A (CsA) and FK506. These drugs bind proteins known as cyclophilin (Cyp) and FK506-binding protein, respectively, and the drug-protein complexes in turn inhibit Cn. We report the crystal structure of a Cyp/CsA/Cn ternary complex, determined to a resolution of 3.1 A. Residues 3-9 of CsA, particularly N-methyl leucines 4 and 6, and Trp-121 of Cyp form a composite surface for interaction with Cn. The hydrophobic interface buries two hydrogen bonds. The structure accounts clearly for the effects of mutations in Cn on CsA-resistance and for the way modifications of CsA alter immunosuppressive activity.

Legend

Protein

Chemical

Disease